D2, D3, D2/D3	placebo	25(OH)D level	1236	1381	Baseline 25(OH)D level was 39.8(11.9) and increased by 3.3(11.6) and 28.6(16.3) nmol/L, in the placebo and active-treatment groups, respectively.
2-weekly and 4-weekly D2-treated groups	baseline	25(OH)D2 AUC140	1519	1634	25(OH)D2 AUC140 was higher in daily than 2-weekly (17%, p = 0.006) and 4-weekly (20%, p = 0.001) D2-treated groups.
